Golden has been acquired by ComplyAdvantage.Read about it here ⟶

Amolyt Pharma

Amolyt Pharma is a therapeutic Peptides founded in 2015.

Overview Structured Data Issues Contributors Activity

amolytpharma.com

Is a

Company

Organization

Company attributes

Industry

Technology

Biotechnology

Biology

Biomedical engineering

Engineering

Location

Lyon

France

CEO

Founder

Pitchbook URL

pitchbook.com/profiles...277552-36

Number of Employees (Ranges)

11 – 50

Full Address

15, chemin du Saquin, Espace Européen, Building G, Ecully, FR

Investors

Kurma Partners

Sofinnova Partners

Anton Gopka

Founded Date

2015

Total Funding Amount (USD)

220,000,000

Latest Funding Round Date

January 6, 2023

Latest Funding Type

Series C

Patents Assigned (Count)

Country

France

Headquarters

Lyon

Other attributes

Company Operating Status

Active

Latest Funding Round Amount (USD)

140,000,000

Public/Private

Private

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Amolyt Pharma

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API